Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Roch Houot, MD, Matthew J Goldstein, Holbrook E Kohrt, MD, June H Myklebust, PhD, Ash A Alizadeh, MD, PhD, Jack T Lin, PhD, Jonathan M Irish, PhD, James A Torchia, Arne Kolstad, MD, PhD, Lieping Chen, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 722.

https://doi.org/10.1182/blood.V114.22.722.722

Published: 2009

Journal Articles

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

June H Myklebust, PhD, Jonathan M Irish, PhD, Roch Houot, MD, Joshua Brody, MD, Debra K Czerwinski, Ash A Alizadeh, MD, PhD, Arne Kolstad, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 759.

https://doi.org/10.1182/blood.V114.22.759.759

Published: 2009

Journal Articles

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

Jonathan M. Irish, PhD, Roch Houot, MD, June H. Myklebust, PhD, Debra K. Czerwinski, Garry P. Nolan, PhD, Ronald Levy, MD

Blood (2008) 112 (11): 377.

https://doi.org/10.1182/blood.V112.11.377.377

Published: 2008

Journal Articles

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Kanutte Huse, M.S, Maren Bakkebo, M.S, Morten Oksvold, PhD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD

Blood (2007) 110 (11): 2605.

https://doi.org/10.1182/blood.V110.11.2605.2605

Published: 2007

Journal Articles

Characterization of Early Human B Cell Development by Gene Expression Profiling.

Marit E. Hystad, PhD, Trond H. Bo, PhD, Edith Rian, PhD, June H. Myklebust, PhD, Einar Sivertsen, MD, Lise Forfang, Michael Chiorazzi, Andreas Rosenwald, MD, Inge Jonassen, PhD, Louis M. Staudt, MD,PhD, Erlend B. Smeland, MD,PhD

Blood (2006) 108 (11): 1352.

https://doi.org/10.1182/blood.V108.11.1352.1352

Published: 2006

Journal Articles

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Kanutte Huse, MS, Marianne B. Eide, MD, Christian Kersten, MD, Erlend B. Smeland, MD, PhD, June H. Myklebust, PhD

Blood (2006) 108 (11): 2381.

https://doi.org/10.1182/blood.V108.11.2381.2381

Published: 2006

NARROW

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Characterization of Early Human B Cell Development by Gene Expression Profiling.

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Email alerts

ASH Publications

American Society of Hematology

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.

Characterization of Early Human B Cell Development by Gene Expression Profiling.

B Cell Lymphomas Are Resistant towards Bone Morphogenetic Protein (BMP) Induced Growth Inhibition.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only